Related Experiment Video
Updated: Aug 2, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation
Jasndeep Kaler1, Azhar Hussain2, Kishan Patel2
1Medicine, Windsor University School of Medicine, Cayon, KNA.
Insights
Respiratory Syncytial Virus (RSV) is a common childhood infection. While most cases are mild, prevention through hygiene and social distancing is key, as no definitive treatment exists.
Area of Science:
- Virology
- Infectious Diseases
- Pediatrics
Background:
- Respiratory Syncytial Virus (RSV) is a leading cause of viral respiratory infections globally, particularly in children under five.
- While RSV affects all age groups, premature infants, young children, the elderly, and immunocompromised individuals face higher risks of severe illness.
- Transmission occurs through respiratory droplets and contaminated surfaces, with infectiousness beginning before symptom onset and varying based on individual factors.
Purpose of the Study:
- To provide a comprehensive overview of Respiratory Syncytial Virus (RSV).
- To discuss RSV transmission, risk factors, and current management strategies.
- To emphasize the importance of preventive measures in controlling RSV spread.
Main Methods:
- Literature review of existing studies on RSV epidemiology, virology, and clinical management.
- Analysis of viral shedding patterns and transmission dynamics.
- Evaluation of current therapeutic and prophylactic interventions, including supportive care and pharmaceutical options.
Main Results:
- RSV has a significant global incidence in young children, posing a risk to vulnerable populations.
- The virus utilizes specific proteins for cell attachment and fusion, initiating replication within host cells.
- Infectiousness precedes symptom onset, with viral shedding duration influenced by infection severity and host immunity.
Conclusions:
- No definitive cure for RSV exists; supportive care is the primary treatment approach.
- Pharmaceutical interventions like ribavirin and palivizumab have limitations regarding cost-effectiveness and side effect profiles.
- Preventive measures, including hand hygiene and social distancing, are crucial for mitigating RSV transmission.
Abstract:
With an increasing global incidence in children younger than the age of five, respiratory syncytial virus (RSV) is one of the most common viral respiratory infections worldwide. Despite the increasing number of cases among infants and young children, RSV can infect any age group; however, some individuals are more high risk than others. Premature infants, young children, elderly, and immunocompromised individuals are the most likely to suffer a more severe presentation of RSV in comparison to healthy adults. RSV is transmitted through respiratory droplets via direct contact with an infected individual or with contaminated surfaces. The viral genome of RSV consists of 11 proteins. Out of these 11, two proteins allow for the attachment of the virus to the respiratory epithelial cells and fusion with host cells. Upon fusion, the viral material transfers to the host cell, where viral replication occurs. It is important to acknowledge that an individual is considered infectious and can transmit the virus even before the symptomatic presentation of RSV begins. As long as the individual is shedding the virus, he or she is considered infectious. The length of viral shedding also differs depending on the severity of the infection, who is infected, and the underlying immune status of an individual. Currently, there is no definitive treatment for RSV; however, supportive therapy is considered the mainstay treatment. Some pharmaceutical treatments such as ribavirin have been FDA-approved; however, the administration is typically limited to children and infants. Palivizumab is also administered as an immune prophylaxis; however, both therapies are constantly at the end of a cost-effective debate due to their extensively expensive nature and questionable adverse effect profiles. Supportive therapy includes hydration, supplemental oxygen, and mechanical ventilation in hospitalized cases; however, most RSV cases can be treated as outpatient cases. Prevention techniques such as hand washing and maintaining social distancing are imperative to minimize the transmission of the virus as much as remotely possible.
Related Concept Videos
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Overview of Respiratory System
What is the Respiratory System?
The respiratory system consists of a series of organs responsible for taking in oxygen and expelling carbon dioxide. The primary function of the respiratory system is to...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

